Skip to main content
    G

    Globus Medical (GMED)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NYSE

    $70.51
    -1.63 (-2.26%)

    Market Cap: $9.57B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Globus Medical (GMED) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Globus Medical (GMED) trades at 14.2x trailing earnings and 3.0x sales. Its P/E of 14.2x is below its 5-year median of 25.1x. Its forward P/E is 13.8x. The median P/E across 9 similar companies is 23.9x.

    Current Multiples

    Its forward P/E is below its trailing P/E, which implies earnings per share about 2.9% higher over the next year. Its free cash flow yield is 8.1%.

    MultipleValue
    P/E (trailing)14.2x
    Forward P/E13.8x
    Price to sales3.0x
    Price to book2.0x
    EV/EBITDA9.4x
    Price to FCF12.3x
    EV/FCF11.8x
    PEG2.8
    FCF yield8.1%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/E is 48.7% below 27.7x, its P/S is 47.4% below 5.7x and its P/B is 41.2% below 3.4x.

    MultipleCurrent5-year median10-year median
    P/E14.2x25.1x27.7x
    P/S3.0x4.3x5.7x
    P/B2.0x2.6x3.4x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 120 months (10-year).

    Valuation History

    Over the 10 year ends shown, its P/E ranged from 20.8x in 2016 to 45.6x in 2020.

    Year endPriceP/EP/SP/B
    2025$87.3121.8x4.0x2.6x
    2024$82.7126.3x4.5x2.8x
    2023$53.2922.9x4.0x1.9x
    2022$74.2735.9x7.3x4.1x
    2021$72.2035.4x7.6x4.3x
    2020$65.2245.6x8.3x4.4x
    2019$58.8834.8x7.4x4.2x
    2018$43.2825.9x6.0x3.7x
    2017$41.1031.6x6.3x4.2x
    2016$24.8120.8x4.2x2.9x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About GMED

    What is GMED's forward P/E ratio?

    Globus Medical has a forward P/E ratio of 13.8x.

    Is GMED stock overvalued?

    GNG's valuation label for GMED is Undervalued. Its P/E of 14.2x compares with a median of 23.9x across 9 similar companies.

    What is GMED's price to sales ratio?

    Globus Medical has a price to sales ratio of 3.0x.

    What is Globus Medical's average P/E ratio over 5 years?

    Globus Medical's median P/E over the last 5 years is 25.1x, from 60 month-end values through Oct 2026.

    What is GMED's PEG ratio?

    Globus Medical has a PEG ratio of 2.8.